Matthew Klimek, PharmD is a Regulatory Program Manager currently working in Product Development Oncology at F. Hoffmann-La Roche Ltd. in BAsel, Switzerland. He completed his Pharm.D. at St. John's University in New Yorl, USA followed by a 2-year fellowship program in regulatory affairs at Schering-Plough/Merck through Rutgers University in Brunswick, NJ, USA. After completing his fellowship, Matt joined Product Developmgent Regulatory Affairs at Roche in Nutley, NJ, USA. Matt has experience working across several therapeutic areas (cardiovascular, metabolic, neurology and oncology) in North America and Asia in both early and late-stage product development. As of September1, 2012, Matt has transitioned from Roche's site in Basel, Switzerland. Matt is currently an EU/ROW regulatory program manager on a late-stage product and a regulatory lead on an early-stage product in Oncology.